Parkman Healthcare Partners’s Natera NTRA Stock Holding History
Bought
Maintained
Sold
Other funds holding NTRA
FAM
SC
FCM
Parkman Healthcare Partners's NTRA Position: Q4 2023 in Review
Parkman Healthcare Partners sold out of Natera (NTRA) in Q4 2023, closing a stake of 50,751 shares — an estimated $2.25M sold.
Parkman Healthcare Partners first reported a position in NTRA in Q4 2019 and held it in 16 quarters. The position peaked at $14.2M in Q1 2021. 351 funds tracked by Wall St. Rank hold NTRA as of Q4 2023.
- Parkman Healthcare Partners reported no remaining Natera position as of Q4 2023 after selling out during the quarter.
- Parkman Healthcare Partners sold 50,751 Natera shares in Q4 2023, an estimated $2.25M.
- Parkman Healthcare Partners first reported a position in Natera in Q4 2019 and held it in 16 quarters.
- Parkman Healthcare Partners's Natera position peaked at $14.2M in Q1 2021.
- 351 funds tracked by Wall St. Rank held Natera as of Q4 2023.
Based on Parkman Healthcare Partners's 13F filing for Q4 2023, filed 14 Feb 2024.